496 related articles for article (PubMed ID: 11504281)
21. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
Segal MR
Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
[TBL] [Abstract][Full Text] [Related]
22. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
[TBL] [Abstract][Full Text] [Related]
23. [Differential gene expression analysis by DNA microarrays technology and its application in molecular oncology].
Frolov AE; Godwin AK; Favorova OO
Mol Biol (Mosk); 2003; 37(4):573-84. PubMed ID: 12942629
[TBL] [Abstract][Full Text] [Related]
24. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
[TBL] [Abstract][Full Text] [Related]
25. [Gene expression profiles in the diagnosis and prognosis of cancer].
Kopper L; Tímár J
Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
[TBL] [Abstract][Full Text] [Related]
26. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
27. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
28. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
29. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
31. Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
Linderoth J; Edén P; Ehinger M; Valcich J; Jerkeman M; Bendahl PO; Berglund M; Enblad G; Erlanson M; Roos G; Cavallin-Ståhl E
Br J Haematol; 2008 May; 141(4):423-32. PubMed ID: 18419622
[TBL] [Abstract][Full Text] [Related]
32. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics.
Booman M; Douwes J; Glas AM; de Jong D; Schuuring E; Kluin PM
J Pathol; 2006 Oct; 210(2):163-71. PubMed ID: 16823896
[TBL] [Abstract][Full Text] [Related]
33. [cDNA microarray technology as a laboratory examination method: a gene expression profiling test for analysis of drug resistance in tumor cells].
Miyachi H; Kobayashi H; Asai S; Shinbata T; Arami S; Mitsuse S
Rinsho Byori; 2002 Feb; 50(2):161-8. PubMed ID: 11925854
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling in cancer using cDNA microarrays.
Khan J; Saal LH; Bittner ML; Chen Y; Trent JM; Meltzer PS
Electrophoresis; 1999 Feb; 20(2):223-9. PubMed ID: 10197427
[TBL] [Abstract][Full Text] [Related]
35. How diagnosis with microarrays can help cancer patients.
Masters JR; Lakhani SR
Nature; 2000 Apr; 404(6781):921. PubMed ID: 10801098
[No Abstract] [Full Text] [Related]
36. Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading.
Bova GS; Parmigiani G; Epstein JI; Wheeler T; Mucci NR; Rubin MA
Hum Pathol; 2001 Apr; 32(4):417-27. PubMed ID: 11331959
[TBL] [Abstract][Full Text] [Related]
37. Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology.
Furusato B; Tsunoda T; Shaheduzzaman S; Nau ME; Vahey M; Petrovics G; McLeod DG; Naito S; Shirasawa S; Srivastava S; Sesterhenn IA
Urology; 2010 Apr; 75(4):768-72. PubMed ID: 20035976
[TBL] [Abstract][Full Text] [Related]
38. A computational neural approach to support the discovery of gene function and classes of cancer.
Azuaje F
IEEE Trans Biomed Eng; 2001 Mar; 48(3):332-9. PubMed ID: 11327501
[TBL] [Abstract][Full Text] [Related]
39. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
Bubendorf L; Kononen J; Koivisto P; Schraml P; Moch H; Gasser TC; Willi N; Mihatsch MJ; Sauter G; Kallioniemi OP
Cancer Res; 1999 Feb; 59(4):803-6. PubMed ID: 10029066
[TBL] [Abstract][Full Text] [Related]
40. Integrative oncogenomic analysis of microarray data in hematologic malignancies.
Martínez-Climent JA; Fontan L; Fresquet V; Robles E; Ortiz M; Rubio A
Methods Mol Biol; 2010; 576():231-77. PubMed ID: 19882266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
